Amerise Biosciences Ltd (531681) — Board Meeting | 1 September 2026
Amerise Biosciences held its 41st Annual General Meeting on 24 September 2026, where shareholders approved the appointment of Albert Hines as Whole Time Director and Chief Financial Officer effective 2 February 2026 on a nil remuneration basis for three years. The meeting covered ordinary business including adoption of audited financial statements for FY2025-26 and special business involving director appointments and authorizations. Proxies and remote e-voting procedures were detailed, with voting open from 21 to 23 September 2026.
About Amerise Biosciences Ltd (531681)
Services · Miscellaneous · Listed on BSE
📡 Get AI alerts when 531681 files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track 531681 — Free💡 Ask AI about this filing
📊 More 531681 filings
No other filings yet.
🔥 Also filed on 1 September 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts for your stocks — summarized by AI daily
Set up your AI Radar — pick stocks, get daily email summaries of new filings.
Set up AI Radar — FreeFree account · 2 AI queries/day
© 2026 StockFin.ai — AI-powered Indian stock research
About · Privacy Policy · Terms of Service · Pricing
Today's Announcements · Screener · Insights · AI Chat
Data provided by CMOTS Internet Technologies Pvt Ltd